Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Upper Extremity Deep-Vein Thrombosis with Fragmin
NCT00245856Phase 4Completed
- Sponsor
- University of Oklahoma
- Start
- Sep 2002
- Primary completion
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dalteparin in deep vein thrombosis (DVT), sponsored by University of Oklahoma. Primary endpoints: Percentage of Participants That Died at 3 months and New Venous Thromboembolism at 3 months. Started Sep 2002; status: completed.
02
Drugs
dalteparin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT00245856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245856.